Friday, 16 October 2026European Markets

KBC And HAL TRUST Have A High Dividend Yield And Return On Equity In The Financial Services Sector.

Loading stream...

(VIANEWS) - KBC (KBC.BR) is among this list of stock assets with the highest dividend rate and return on equity on the Financial Services sector.

Financial Asset Price Forward Dividend Yield Return on Equity
KBC (KBC.BR) €60.62 10.08% 13.72%
HAL TRUST (HAL.AS) €124.60 1.94% 3.3%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. KBC (KBC.BR)

10.08% Forward Dividend Yield and 13.72% Return On Equity

KBC Group NV, together with its subsidiaries, provides integrated bank-insurance services primarily for retail, private banking, small and medium sized enterprises, and mid-cap clients. The company offers demand deposits and savings accounts; home and mortgage loans; consumer finance and SME funding services; credit, investment fund and asset management, and life and non-life insurance; and cash management, payments, trade finance, lease, money market, capital market products, and stockbroking services. It also provides digital and mobile banking services. The company was formerly known as KBC Bank and Insurance Holding Company NV and changed its name to KBC Group NV in March 2005. KBC Group NV was incorporated in 1935 and is headquartered in Brussels, Belgium.

Earnings Per Share

As for profitability, KBC has a trailing twelve months EPS of €7.49.

PE Ratio

KBC has a trailing twelve months price to earnings ratio of 8.09. Meaning, the purchaser of the share is investing €8.09 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.72%.

Sales Growth

KBC's sales growth for the next quarter is 11.7%.

More news about KBC.

2. HAL TRUST (HAL.AS)

1.94% Forward Dividend Yield and 3.3% Return On Equity

HAL Trust, together with its subsidiaries, operates through multi-sectors in Europe, the United States, Canada, Asia, and internationally. The company operates through Unquoted, Quoted Minority Interests, Real Estates, and Liquid Portfolio segments. It engages in production of composite panels; residential construction, utility construction, project development, and renovation activities; supply of timber products and building materials; and develop, distributes, and e-commerce computer gaming equipment. The company also provides furniture and fit-out services; sells medical and hearing aid products; offers shipping, greenhouse construction, information and data, credit management, and factoring services; and operates temporary staffing agency, optical retail chain, mortgage funding, and greenhouse projects, as well as offers certification and benchmarking human resource polices. In addition, it manufactures and distributes optical frames and sunglasses; and design, builds, installs, and operates offshore floating facilities, as well as provides tank storage services. Further, the company engages in the development and rental of retail centers, multi-family properties, and office buildings; and investment in grade bonds; and provision of financial assets, including marketable securities and cash-equivalent instruments. Additionally, it invests in GHG reduction projects; and offers financial services, building materials, orthopedic devices, and tank terminal services. The company was founded in 1873 and is based in Willemstad, Curaçao.

Earnings Per Share

As for profitability, HAL TRUST has a trailing twelve months EPS of €7.37.

PE Ratio

HAL TRUST has a trailing twelve months price to earnings ratio of 16.91. Meaning, the purchaser of the share is investing €16.91 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.3%.

More news about HAL TRUST.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com